Akebia therapeutics inc.

Major-Pharmaceuticals

AKBA


245 First Street
Cambridge , MA 02142

Executive/
Director

Price

  • Last Close
  • $ 1.52
    $ -0.01 -0.65 %
    Aug 29, 2024
  • 52-Week High/Low
  • $2.22 - $0.8
  • YTD
  • 22.6%

  • Trading Volume
  • 35,488
  • Market Cap Full
  • $ 286.4M
  • Shares Outstanding
  • 188.4M
    Nov 6, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -4.6% -30.3% -11.6% -35.9% 48.1% -5% 20.9% -68.2% -3% 47.6%
Q2 -7.4% -17% 56.2% 1.2% -40.9% 4% 12% -50.8% 63.4% -3.1%
Q3 -6.1% 21% 36.9% -7.8% -15.5% 8% -24% -10.5% 24.6% -
Q4 33.8% 15% -24.1% -35% 63.1% 11.6% -21.5% 82.6% 7.8% -
J F M A M J J A S O N D
2024 35.5% -6% 15.8% -13.7% - - - - - - - -
2023 9.2% 33.8% -33.6% 62.3% 14.4% -12% 82.5% -16.8% -18% -22.8% 20.5% 17%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%11%-19%43%-63%18%-57%-19%-74%115%23%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.53 0.70 1.15 -0.48 -0.62 -0.47 -0.45 -0.35 -0.14
Q2 0.40 0.95 0.53 -0.6 -0.49 -1.28 -0.51 0.15 -0.06
Q3 0.68 0.96 0.49 -0.46 -0.46 -0.42 -0.34 -0.28 -0.08
Q4 0.66 0.99 0.25 -0.93 -0.79 -0.6 -0.4 -0.03 -
A 2.3 3.6 2.4 -2.5 -2.4 -2.8 -1.7 -0.5 -0.28

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 117.1 129.9 153.5 181.2 184.2
Jun 56.9 117.9 130.3 160.1 183.5 185.9
Sep 57 118.9 143.3 174.5 183.8 188.3
Dec 57.1 118.9 144.5 175 184 188.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 3.9 4 3 1.3 0.1
Fixed Asset Turnover 29.3 3.8 6.3 3.9 1.4
Total Asset Turnover 0.8 0.4 0.5 0.4 0.2
Leverage
Debt Ratio 0.2 - 0.3 0.3 -
Debt – Equity Ratio 6.8 - 0.4 0.2 -
Interest Coverage -5.6 -14.7 -53.7 47.7 5.2
Equity multiplier 2 0.8 0.2 0.2 0.2